ClinicalTrials.govpublic full text
Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma
esophagus cancer, adenocarcinoma, stomach cancer, adenocarcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802640
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.